Establishment of cDNA microarray analysis at the Genomic Medicine Research Core Laboratory (GMRCL) of Chang Gung Memorial Hospital.

BACKGROUND Advances in molecular and computational biology have led to the development of powerful, high-throughput methods for analysis of differential gene expression, which are opening up new opportunities in genomic medicine. DNA microarray technology has been enthusiastically integrated into basic biomedical research and will eventually become a molecular monitoring tool for various clinical courses. METHODS As a core research facility of Chang Gung University (CGU) and Chang Gung Memorial Hospital (CGMH), the Genomic Medicine Research Core Laboratory (GMRCL) welcomes investigators from every discipline to employ DNA microarray technology in the quest for knowledge of genomic medicine. The first tasks for GMRCL are to optimize the standard operating procedures (SOP) for each instrument and to assure the quality of every procedure. RESULTS During the first year after the establishment of the GMRCL at the CGMH, we tested and adopted procedures that were satisfactory for our purposes. These procedures included: replication of bacterial stocks, amplification of human DNA clones, annotation of each DNA clone, production of cDNA microarrays, validation of RNA quality and quantity, labeling of target specimens, competitive hybridization, scanning of slides, data analysis, and post-microarray validation of results. We present a summarization of the materials and procedures used at the GMRCL and discuss the reasons for using them. CONCLUSIONS The information about the cDNA microarray analysis system at the GMRCL is compliant with the minimal information about a microarray experiment (MIAME) format. The information may be useful to both the investigators who are using this core facility and researchers at other institutes, who will establish their own in-house cDNA microarray systems.

[1]  S. P. Fodor,et al.  Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays , 1999, Nature Genetics.

[2]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[3]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[4]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[5]  N. Lee,et al.  A concise guide to cDNA microarray analysis. , 2000, BioTechniques.

[6]  G. Ramsay DNA chips: State-of-the art , 1998, Nature Biotechnology.

[7]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[8]  J. Hacia Resequencing and mutational analysis using oligonucleotide microarrays , 1999, Nature Genetics.

[9]  J. Blake,et al.  Creating the Gene Ontology Resource : Design and Implementation The Gene Ontology Consortium 2 , 2001 .

[10]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[11]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[12]  J. Carulli,et al.  High throughput analysis of differential gene expression , 1998, Journal of cellular biochemistry.

[13]  C. Perou,et al.  Molecular portraits and the family tree of cancer , 2002, Nature Genetics.

[14]  Microarray standards at last , 2002, Nature.

[15]  Ash A. Alizadeh,et al.  Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Kohn,et al.  Cancer's deadly signature , 2003, Nature Genetics.

[17]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[18]  G. Churchill Fundamentals of experimental design for cDNA microarrays , 2002, Nature Genetics.

[19]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[20]  J. Downing,et al.  Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells , 2003, Nature Genetics.

[21]  M. Sussman,et al.  Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array , 1999, Nature Biotechnology.

[22]  E. Southern,et al.  Determining the influence of structure on hybridization using oligonucleotide arrays , 1999, Nature Biotechnology.

[23]  P. F. Macgregor,et al.  Application of microarrays to the analysis of gene expression in cancer. , 2002, Clinical chemistry.

[24]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[25]  D. Gerhold,et al.  Better therapeutics through microarrays , 2002, Nature Genetics.

[26]  J. Blake,et al.  Extension and integration of the gene ontology (GO): combining GO vocabularies with external vocabularies. , 2002, Genome research.